Contrary to the "live forever" narrative, the primary goal of serious, government-funded aging research is to increase "healthspan"—the portion of life spent in good health. The focus is on addressing the societal challenge of aging populations by improving quality of life, not radically extending lifespan itself.

Longevity's goal shouldn't just be living free of disease ('health span'). The new frontier is 'performance span': actively maintaining the ability to perform at a high level, both physically and cognitively, well into old age, challenging the assumption that decline is inevitable.

Society must abandon chronological age as a proxy for ability. People in their 30s can be non-functional, while centenarians can be perfectly functional. The focus should shift to an individual's actual health and capacity, unlocking the potential of older individuals instead of devaluing them based on their birth date.

While people are living longer, they are spending more of those years managing chronic illness and disability. This growing gap between lifespan (how long you live) and health span (how long you live well) points to a crisis in preventative and metabolic health.

Beyond tackling fatal diseases to increase lifespan, a new wave of biotech innovation focuses on "health span"—the period of life lived in high quality. This includes developing treatments for conditions often dismissed as aging, such as frailty, vision loss, and hearing decline, aiming to improve wellbeing in later decades.

While extending life seems desirable, the certainty of death is what gives our '4,000 weeks' a sense of urgency and purpose. Living to 160 or beyond could foster a 'mañana' mentality, where difficult choices and ambitious projects are perpetually delayed, diluting the richness of the human experience.

A major transformation has occurred in longevity science, particularly in the last eight years. The conversation has moved away from claims of radical life extension towards the more valuable goal of increasing "healthspan"—the period of healthy, functional life. This represents a significant and recent shift in scientific consensus.

The current medical model, which treats diseases one by one as they appear, is flawed for an aging population. It extends life but leads to a rise in overall frailty and disability. The only effective path forward is to directly target the underlying biological process of aging to extend healthspan.

As societies enable most people to live longer, they inevitably encounter the biological limits of aging. This deceleration in life expectancy gains isn't a medical failure but a natural consequence of success, proving we've reached a point where we must target aging itself, not just individual diseases.